Reports & Briefings
Navigate forward to interact with the calendar and select a date. Press the question mark key to get the keyboard shortcuts for changing dates.
Navigate backward to interact with the calendar and select a date. Press the question mark key to get the keyboard shortcuts for changing dates.
September 20, 2023
Big Tech’s Free Online Services Aren’t Costing Consumers Their Privacy
There is no evidence that breaking up big online platforms will improve digital privacy, but there is overwhelming evidence that breaking up these services or restricting them from collecting user data will harm consumers and workers.
September 14, 2023
Latin American Subnational Innovation Competitiveness Index
For policymakers to bolster the global competitiveness of their nations and regions, they first must know where they stand. This report benchmarks the 182 regions of Brazil, Chile, Colombia, Mexico, Peru, and the United States using 13 commonly available indicators of strength in the knowledge economy, in globalization, and in innovation capacity.
September 14, 2023
Transatlantic Subnational Innovation Competitiveness Index 2.0
For policymakers to bolster the global competitiveness of their nations and regions, they first must know where they stand. This report benchmarks the 121 regions of Austria, Germany, Hungary, Italy, Poland, Sweden, and the United States using 13 commonly available indicators of strength in the knowledge economy, globalization, and innovation capacity.
September 11, 2023
How Expanding the Information Technology Agreement to an “ITA-3” Would Bolster Nations’ Economic Growth
Completing a second expansion of the Information Technology Agreement (an “ITA-3”) could bring more than 400 unique ICT products under the ITA’s tariff-eliminating framework, which would add more than $750 billion to the global economy over 10 years.
September 5, 2023
How Skeptics Misconstrue the Link Between Drug Prices and Innovation
A recent article in the British Medical Journal contends “high drug prices” are neither necessary nor justified to sustain biopharmaceutical innovation. But it misrepresents and misinterprets the facts, highlighting how faulty the rationale is for drug price controls.
September 5, 2023
Comparing Data Policy Priorities Around the World
Instead of duplicating any one approach, U.S. policymakers should borrow from the menu of options to craft a cohesive, pro-innovation data strategy.
August 28, 2023
ITIF Technology Explainer: DOCSIS 4.0
Data Over Cable Service Interface Specifications (DOCSIS) is an industry standard, set by cable industry group CableLabs, that specifies high-bandwidth data communications. DOCSIS 4.0 is the latest standard.
August 21, 2023
Preserving US Biopharma Leadership: Why Small, Research-Intensive Firms Matter in the US Innovation Ecosystem
America is home to 85 percent of the world’s small, research-intensive biopharma firms. These start-ups are critical to drug development and U.S. competitiveness. Congress should make targeted changes to tax policy to incentivize them and maintain U.S. biopharma leadership.
August 14, 2023
Enabling Equity: Why Universal Broadband Access Rates Matter
High rates of broadband adoption benefit all of society, yet those who stand to benefit the most are also least likely to be online. Pushing hard for near-universal connectivity is crucial if we want technology to help bridge, rather than widen, existing divides.
August 7, 2023
Developing an R&D Strategy to Integrate Immersive Learning Into the Classroom
Introducing immersive technologies into classrooms has the potential to make the U.S. education system more effective. But before these technologies are deployed in schools, the federal government should increase R&D investments in key areas that need further research.